PT Catur Sentosa Adiprana Tbk (IDX:CSAP)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,477,626	2,762,023	3,438,321	3,633,558	2,184,593	1,720,924
Market Cap Growth	-50.40%	-19.67%	-5.37%	66.33%	26.94%	-14.22%
Enterprise Value	6,242,422	7,419,663	7,401,046	7,561,201	5,385,377	4,012,664
Last Close Price	260.00	473.05	580.61	767.10	454.28	355.16
PE Ratio	11.30	14.94	18.85	15.20	10.33	28.46
Forward PE	-	17.86	17.86	17.86	17.86	17.86
PS Ratio	0.09	0.16	0.21	0.24	0.15	0.14
PB Ratio	0.40	0.75	0.98	1.46	0.96	0.84
P/TBV Ratio	0.43	0.80	1.04	1.58	1.05	0.92
P/FCF Ratio	9.53	-	-	-	-	288.56
P/OCF Ratio	2.39	13.59	7.08	13.25	26.25	2.94
EV/Sales Ratio	0.36	0.43	0.45	0.49	0.38	0.32
EV/EBITDA Ratio	6.68	8.80	9.36	8.95	7.67	8.16
EV/EBIT Ratio	11.34	12.09	12.49	11.58	9.94	11.18
EV/FCF Ratio	40.27	-	-	-	-	672.82
Debt / Equity Ratio	1.27	1.34	1.17	1.56	1.45	1.26
Debt / EBITDA Ratio	4.99	4.79	4.37	4.01	4.09	4.51
Debt / FCF Ratio	30.11	-	-	-	-	435.22
Asset Turnover	1.48	1.46	1.57	1.70	1.77	1.78
Inventory Turnover	3.91	3.70	3.86	4.03	4.43	4.30
Quick Ratio	0.36	0.33	0.38	0.38	0.41	0.47
Current Ratio	1.00	1.01	1.05	1.05	1.10	1.09
Return on Equity (ROE)	3.91%	5.54%	6.89%	11.06%	10.43%	3.02%
Return on Assets (ROA)	2.93%	3.25%	3.53%	4.50%	4.20%	3.16%
Return on Capital (ROIC)	4.17%	4.74%	5.29%	6.83%	6.64%	5.36%
Return on Capital Employed (ROCE)	9.40%	10.40%	10.60%	14.90%	13.40%	10.10%
Earnings Yield	8.84%	6.69%	5.31%	6.58%	9.68%	3.51%
FCF Yield	10.49%	-16.13%	-20.02%	-4.09%	-15.53%	0.35%
Dividend Yield	2.50%	1.37%	1.21%	1.43%	-	1.13%
Payout Ratio	30.47%	21.52%	26.88%	16.78%	8.43%	14.74%
Buyback Yield / Dilution	-1.54%	-14.38%	-11.45%	-	-	-
Total Shareholder Return	0.96%	-13.01%	-10.24%	1.43%	-	1.13%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.